MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

24 Aug 2024 Evaluate
Alembic Pharmaceuticals has informed that it enclosed press release itled ‘Alembic Pharmaceuticals receives USFDA Final Approval for Betamethasone Valerate Foam, 0.12%.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..